DonSDizonMDFACP(he/him)

PubMed

• Effects of a change in recall period on reporting severe symptoms: an analysis of a pragmatic multisite trial.
  Paudel, R., Uno, H., Cronin, C., Wong, S., Hazard Jenkins, H., Bian, J., Jensen, R., Mitchell, S., Enzinger, A., Dizon, D., Osarogiagbon, R., Schrag, D., Hassett, M.> ;Journal of the National Cancer Institute. 2024 Mar 5
• Cancer statistics 2024: All hands on deck.
  Dizon, D., Kamal, A.> ;CA. 2024 Jan 17
• 1 citations
  The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel method.
  Justin D Smith, Wynne E Norton, Sandra A Mitchell, Christine Cronin, Michael J Hassett, Jennifer L Ridgeway, Sofia F Garcia, Raymond U Osarogiagbon, Don S Dizon, Jessi...> ;Implementation Science Communications. 2023 Nov 28
• Assessing Patient Readiness for an Electronic Patient-Reported Outcome-Based Symptom Management Intervention in a Multisite Study.
  Roshan Paudel, Angela C Tramontano, Christine Cronin, Sandra L Wong, Don S Dizon, Hannah H Jenkins, Jessica Bian, Raymond U Osarogiagbon, Deborah Schrag, Michael J Has...> ;JCO Oncology Practice. 2024 Jan 1
• Evaluating Patient Experience in a Multidisciplinary Breast Cancer Clinic: A Prospective Study.
  Stephanie L Graff, Julie Principe, Anne Marie Galvin, Mary Anne Fenton, Rochelle Strenger, Laura Salama, Rani Bansal, Don S Dizon, Megan H Begnoche> ;Journal of Women's Health. 2024 Jan 1
• Lung cancer screening guidelines: Smoking matters, not quitting.
  Don S Dizon, Arif H Kamal> ;CA. 2023 Nov 1
• 1 citations
  State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities.
  Charles S Kamen, Don S Dizon, Chunkit Fung, Mandi L Pratt-Chapman, Mark Agulnik, Lola A Fashoyin-Aje, Sanford E Jeames, Janette K Merrill, Kimberly T Smith, Shail Maingi> ;JCO Oncology Practice. 2023 Nov 1
• 1 citations
  Opposing Roles ofMutations in Human Prostate and Endometrial Cancers.
  Ludimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, Benedito A Carneiro, Don S Dizon, Kartik Angara, Tyler Mattox, Sharon Wu, Joanne Xiu, Phillip Walker, M...> ;JCO Precision Oncology. 2023 Sep 1
• Sequencing systemic therapy in hormone-receptor positive metastatic breast cancer: a modern paradigm.
  Stephanie A Haddad, Don S Dizon, Stephanie L Graff> ;Chinese Clinical Oncology. 2023 Aug 1
• 1 citations
  Spatial Heterogeneity in Cytoskeletal Mechanics Response to TGF-β1 and Hypoxia Mediates Partial Epithelial-to-Meshenchymal Transition in Epithelial Ovarian Cancer Cells.
  Deepraj Ghosh, Kylen Soriano, Carolina Mejia Peña, Amy H Lee, Don S Dizon, Michelle R Dawson, Hsu, J., Jeffrey Hsu> ;Cancers. 2023 Jun 14
• Addendum:: a novel gene fusion in hepatic angiosarcoma.
  Eric I Marks, Sahithi Pamarthy, Don Dizon, Ari Birnbaum, Evgeny Yakirevich, Howard Safran, Benedito A Carneiro> ;Oncotarget. 2023 May 26
• 16 citations
  Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update.
  Barbara L Andersen, Christina Lacchetti, Kimlin Ashing, Jonathan S Berek, Barry S Berman, Sage Bolte, Don S Dizon, Barbara Given, Larissa Nekhlyudov, William Pirl, Ann...> ;Journal of Clinical Oncology. 2023 Jun 20
• 2 citations
  Predictors and impact of survivorship care plans and survivorship care visits.
  Harish Saiganesh, Christine Duffy, Stavroula A Chrysanthopoulou, Don S Dizon> ;Journal of Cancer Survivorship. 2023 Jan 24
• 1 citations
  Identifying Credible Sources of Health Information in Social Media: Phase 2-Considerations for Non-Accredited Nonprofit Organizations, For-Profit Entities, and Individ...
  Helen Burstin, Susan Curry, Megan L Ranney, Vineet Arora, Brian Boxer Wachler, Wen-Ying Sylvia Chou, Ricardo Correa, Donna Cryer, Don Dizon, Efrén J Flores, Gerald Har...> ;NAM Perspectives. 2023 Jan 1
• 2 citations
  Global Breast Cancer Initiative: A platform to address the psycho-oncology of cancer in low- and middle-income countries for improving global breast cancer outcomes.
  Cristiane Decat Bergerot, Don S Dizon, Andre M Ilbawi, Benjamin O Anderson> ;Psycho-Oncology. 2023 Jan 1
• Using social media for patient-driven cancer research.
  Rami Manochakian, Don S Dizon> ;Nature Reviews. Cancer. 2023 Jan 1
• 4 citations
  Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data.
  Ash B Alpert, Jamie Renee Brewer, Spencer Adams, Lexis Rivers, Sunshine Orta, John R Blosnich, Susanne Miedlich, Charles Kamen, Don S Dizon, Richard Pazdur, Julia A Be...> ;Journal of Clinical Oncology. 2023 Apr 1
• 1 citations
  Small cell neuroendocrine carcinoma of vagina: Report of a unique case with literature review.
  Tip Pongsuvareeyakul, Maria Garcia-Moliner, Elizabeth Lokich, Don S Dizon, Kamaljeet Singh> ;Cancer Treatment and Research Communications. 2022 Jan 1
• 3 citations
  Understanding Modern Medical Centers: Beyond Simone-Intersectional Maxims for a New Era.
  Stephanie L Graff, Tanya Wildes, Narjust Duma, Don S Dizon, Noelle K LoConte, Edith Mitchell, Martina C Murphy, Edith A Perez, Sarah M Temkin, Pamela L Kunz, Karen M W...> ;Journal of Clinical Oncology. 2023 Mar 1
• 7 citations
  Call for action: expanding global access to hereditary cancer genetic testing.
  Brittany Bychkovsky, Huma Q Rana, Foluso Ademuyiwa, Jennifer Plichta, Karen Anderson, Angélica Nogueira-Rodrigues, Cesar A Santa-Maria, Lan G Coffman, Carol Marquez, A...> ;The Lancet. Oncology. 2022 Sep 1
• 2 citations
  Objective Impact of Hematology-Oncology Hospitalist Care in an Inpatient Setting.
  Kristina A Fanucci, Andrew Yang, Alison Chambers, Don Dizon, Howard Safran, Rabin Niroula> ;JCO Oncology Practice. 2022 Oct 1
• 4 citations
  Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
  Andrew G Shuman, Matti S Aapro, Benjamin Anderson, Katherine Arbour, Pedro C Barata, Aditya Bardia, Eduardo Bruera, Bruce A Chabner, Herbert Chen, Edwin Choy, Pierfran...> ;The Oncologist. 2022 Aug 13
• 2 citations
  Social Media and Oncology: The Time Is Now.
  Deanna J Attai, Don S Dizon> ;JCO Oncology Practice. 2022 Aug 1
• Social Media and the Quest for Equity and Diversity in Oncology: On Safe Spaces and the Concept of the Public Physician.
  Narjust Florez, Maimah Karmo, Sara Beltrán Ponce, Maura M Barry, Elizabeth Henry, Matthew S Katz, Don S Dizon, Heather M Hylton> ;JCO Oncology Practice. 2022 Aug 1
• 1 citations
  Ethics-Centered Guidelines for Social Media Use by Oncology Professionals: A Call to Action.
  Utkarsh C Shukla, Rachel B Jimenez, Reshma Jagsi, Abby R Rosenberg, Jonathan M Marron, Laura J Carfang, Colleen A Lawton, Don S Dizon, Matthew S Katz> ;JCO Oncology Practice. 2022 Aug 1
• Join now to see all

Journal Articles

• Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials  
  Mina S Sedrak, Don S Dizon, JAMA Network Open
• Personalizing chemotherapy through genetic profiling: will pharmacogenomics help improve and extend life for cancer patients?  
  K Hachey and DS Dizon, Personalized Medicine, 2009; 6:481-4
• Dyspareunia and vaginal dryness after breast cancer treatment.  
  DL Wiggins and DS Dizon, Sexuality, Reproduction, and Menopause, 2008: 18-22
• HER dimerization inhibitors: Developing pertuzumab as an anti-cancer agent in women’s oncology.  
  DS Dizon and S Makhija, Expert Opinion in Drug Discovery, 2008; 11:1363-69
• Breast Cancer Follow-Up; Extending the focus beyond survival.  
  S MacLaughlan and DS Dizon, Journal Watch Women’s Health, March 2009; 14:19-20
• Sexuality and intimacy following cancer.  
  MA Kunz and DS Dizon, US Obstetrics & Gynecology 2009; 3:21-23
• Sexual ramifications of medical illness.  
  K. Perez, M Gadgil, and DS Dizon, Clinics of Obstetrics and Gynecology 2009; 52:691-701
• Short Communication: Palmar-plantar erythrodysesthesia is not related to body mass index in patients receiving pegylated liposomal doxorubicin.  
  ME Gordinier, DS Dizon, EL Fleming, S Weitzen, CO Granai, Gynecol Oncol 2006; 103:72-4
• Benzylisothiocyanate (BITC) induces apoptosis in ovarian cancer cells in vitro.  
  S Kalkunte, N Swamy, DS Dizon, L Brard, J Exp Ther Oncol. 2006; 5:287-300
• HER-Dimerization Inhibitors: Evaluating pertuzumab in women’s cancers.  
  K Kristjansdottir and DS Dizon, Expert Opinion on Biologic Therapy. 2010; 10:243-50
• Breast cancer: adjuvant modalities.  
  Sakr BJ and Dizon DS, Clin Obstet Gynecol 2011; 54:150-6
• New advances in the treatment of endometrial cancer.  
  Roque DR and Dizon DS, Clin Invest 2011; 1:413-422
• Anti-mitotic inhibitors.  
  Campos SM and Dizon DS, Hematology and Oncology clinics 2012; 26: 607-628
• Evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: a Gyn...  
  Dizon DS, Blessing JA, Penson RT, Drake RD, Walker JL, Johnston CM, Disilvestro PA, Fader AN, Gyn Oncology 2012; 125:367-371
• Locally advanced vulvar cancer in elderly women: is chemoradiation beneficial?  
  A Stuckey, M Schutzer, T Rizack, and DS Dizon, Am J Clin Oncol 2012; Epub Ahead of print
• Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient.  
  DS Dizon, T Tejada-Berges, S Koelliker, M Steinhoff, and CO Granai, J Gynecol and Obstet Invest 2006; 62:226-228
• Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva.  
  Horowitz NS, Olawaiye AB, Borger DR, Growdon WB, Krasner CN, Matulonis UA, Liu JF, Lee J, Brard L, and Dizon D, Gyn Oncol 2012; 127:141-6
• Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer.  
  DS Dizon, L Damstrup, NJ Finkler, U Lassen, P Celano, R Glasspool, E Crowley, HS Lichenstein, P Knoublach, RT Penson, Inter Journal of Gynecol Cancer 2012; 22:979-86
• The differential diagnosis of dyspnea in a woman with metastatic breast cancer: Consideration beyond pulmonary embolism.  
  DS Dizon, J Beheshti, K McDonough, J Gass, The Breast Journal, 2008; 14:90-1
• A phase II study of patupilone (EPO906) in patients with platinum-resistant or –refractory ovarian cancer.  
  Smit WM, Sufliarsky J, Werner TL, Dizon DS, Wagnerova M, Hirte HW, Spiritos NM, Oza A, Dirix L, El-Hasimy M, Acharyya S, Tan EY, Weber D, and Schellens JHM, Clin Ovarian Cancer and Other Gynecologic Cancers
• Stage IV small bowel carcinoma mimicking advanced ovarian cancer: case report and review of the literature.  
  DS Dizon, K Perez, P DiSilvestro, C Taneja, D Ilson, American Surgeon 2009; 75:864-5
• Is Tumor Board Relevant?  
  Rizack T, Gass JS, Legare RD, Sakr BJ, Dizon DS, The Breast Journal
• Management of ovarian cancer: balancing therapy and quality of life.  
  DS Dizon and PJ Sabbatini, Oncol Spec Ed. 2002; 5:1-6
• Intrahepatic arterial infusion of chemotherapy: clinical results.  
  DS Dizon and N Kemeny, Sem in Oncol 2002; 29:126-135
• Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.  
  DS Dizon, J Schwartz, N Kemeny, Surg Oncol Clin N Am, 2008; 17:759-71
• Join now to see all

Books/Book Chapters

• Precis: an Update in Obstetrics and Gynecology. 
  Chapter: Long term quality of life and symptoms management for women with cancer 
  Page 126 - 138RT Penson and DS DizonEditors: JS Berek, et al.American College of Obstetrics & Gynecology, Washington, DCEdition 3,
• Gene Therapy of Cancer: Methods and Protocols. 
  Chapter: Methods for Chemoprotection and Chemo-sensitization: MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors 
  Page 609 - 616S Srimdkandada, T Fujii, T Wang, SQ Fu, LH Yin, XYD Guo, T Nanakorn, XY Peng, WL Wang, L Zhang, A Canaan, M Anderson, D Dizon, D Lin, M Cooperberg, R Loewe, S Savinov,...Editors: W. Walther, and U. Stein.Humana Press, Totowa, New Jersey
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Adjuvant Chemotherapy After Hepatic Resection for Metastatic Colorectal Carcinoma 
  Page 359 - 366N Kemeny and DS DizonEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Locoregional Chemotherapy for Metastatic Colorectal Cancer to the Liver 
  Page 367 - 374DS Dizon and N KemenyEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz, London
• Principles & Practice of Cancer Rehabilitation. 
  Chapter: Sexuality 
  DS Dizon and M KrychmanEditors: M Stubblefield, M O’Dell, C Custodio, and T Fitzpatrick.Demos, New York
• Female Sexual Pain Disorders: Evaluation and Management. 
  Chapter: Cancer and Dyspareunia 
  MA Krychman, DS Dizon, A Amsterdam, A PartridgeEditors: Goldstein, Pukall, and Goldstein.Blackwell, Towson
• Atlas of Cancer. 
  Chapter: Management of Non-Epithelial Ovarian Cancers 
  Page 100 - 105DS Dizon, E Poynor, and ML HensleyEditors: M Markman.Lippincott, Williams, & Wilkins, Philadelphia
• Principles and Practice of Gynecologic Oncology. 
  Chapter: Breast Cancer 
  DS Dizon, T Tejada-Berges, MM Steinhoff, CJ Sung, S Koelliker, HI Khalil, B O’Connor, S MacAusland, C Taneja, RD Legare, and JS GassEditors: Barakat, Markman, and Randall.Lippincott Williams and Wilkins
• The European Society of Gynecologic Oncologists’ Handbook for Fellows in Gynecologic Oncology. 
  Chapter: Choosing treatments for recurrent ovarian cancer: the platinum-free interval 
  A Stuckey and DS DizonEditors: M. Gultekin.
• The European Society of Gynecologic Oncologists’ Handbook for Fellows in Gynecologic Oncology. 
  Chapter: Choosing treatments for recurrent ovarian cancer: the platinum-free interval 
  A Stuckey and DS DizonEditors: M. Gultekin.Edition 2,
• Cancer and Sexual Health. 
  Chapter: Evaluation of the female with sexual dysfunction 
  ML Krychman, D Dizon, A Amsterdam, S Kellogg SpadtEditors: JP Mulhall, L Incrocci, I Goldstein, R Rosen.SpringerLink, New York
• DxRx Cervical Cancer: An approach to preinvasive and invasive malignancies of the cervix. 
  K Robison and DS DizonJones and Bartlett, Sudbury, MA
• Gynecologic Tumor Board: Clinical Cases in the Diagnosis and Management of Cancer of the Female Reproductive System. 
  DS DizonEditors: DS Dizon and NA Rustum.Jones and Bartlett, Sudbury, MA
• DxRx Gynecologic Cancers. 
  SM Campos and DS DizonJones and Bartlett, Sudbury, MA
• DxRx Cervical Cancer: An approach to preinvasive and invasive malignancies of the cervix. 
  K Robison and DS DizonJones and Bartlett, Sudbury, MAEdition 2,
• A Methods for Chemoprotection and Chemo-sensitization: MDR-1 For Chemoprotection Using Retroviruses to Modify Hematopoietic Cells and Cytosine Deaminase for Chemosensitization Using Adenoviral Vectors 
  Page 609 - 616S Srimdkandada, T Fujii, T Wang, SQ Fu, LH Yin, XYD Guo, T Nanakorn, XY Peng, WL Wang, L Zhang, A Canaan, M Anderson, D Dizon, D Lin, M Cooperberg, R Loewe, S Savinov,...Editors: W. Walther, and U. Stein.Humana Press, Totowa, New Jersey
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Adjuvant Chemotherapy After Hepatic Resection for Metastatic Colorectal Carcinoma 
  Page 359 - 366N Kemeny and DS DizonEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz, London
• Colorectal Cancer: A Clinical Guide to Therapy. 
  Chapter: Locoregional Chemotherapy for Metastatic Colorectal Cancer to the Liver 
  Page 367 - 374DS Dizon and N KemenyEditors: Bleiberg M, Kemeny N, Rougier PH, Wilke HJ.Martin Dunitz, London
• Atlas of Cancer. 
  Chapter: Management of Non-Epithelial Ovarian Cancers 
  Page 100 - 105DS Dizon, E Poynor, and ML HensleyEditors: M Markman.Lippincott, Williams, & Wilkins, Philadelphia
• Cancer Drug Discovery and Development: Combination Cancer Therapy: Modulators and Potentiators. 
  Chapter: Targeting NF-kB to increase the actibity of cisplatin in solid tumors 
  Page 197 - 207DS Dizon, C Aghajanian, XJ Yan, D SpriggsEditors: Schwartz, G.K.Humana Press, Totowa, NJ
• Chemotherapy for Gynecologic Neoplasms: Current Therapy and Novel Approaches. 
  Chapter: Persistent and recurrent ovarian cancer 
  Page 407 - 432DS Dizon and DR SpriggsEditors: Penalver M, Angioli R, Panici PB, Kavanagh J, Pecorelli S.Dekker, New York
• Join now to see all

Abstracts/Posters

• A subset of genes is upregulated in the SKOV-3 cell line following treatment with cisplatin, following development of platinum-resistance, and after transfection of an...
  DS Dizon, XJ Yan, N Rosales, CA Aghajanian, DR Spriggs, National Cancer Institute/European Organization for Research and Treatment of Cancer, American Association for Cancer Research (NCI/EORTC/AACR) Oncogenomics Conference 2002. Dublin, Irel
• Early Finding in a Phase I study of the novel high affinity VEGF binder VEGF Trap in patients with refractory solid tumors and lymphoma.
  J Dupont, C Aghajanian, P Chapman, D Dizon, J Koutcher, L Krug, R Motzer, P Sabbatini, L Schwartz, S Sharma, D Camastra, S Pezzulli, V Ty, M Gordon, J Murren, A Lucare..., National Cancer Institute/European Organization for Research and Treatment of Cancer, American Association for Cancer Research (NCI/EORTC/AACR) International Conference
• Phase I/II Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer.
  WW ten Bokkel Huinik, WM Smit, J Sufliarsky, DS Dizon, AM Oza, J-M Culillerot, KJ Williams, A Johri, International Gynecologic Cancer Society Annual Meeting, Santa Monica, CA
• Advanced Care Planning and Primary Support in Women with Gynecologic Cancers: Results from a Pilot Study at an Academic Program in Women’s Oncology.
  DS Dizon, C Bandera, S Weitzen, and MA Clark, 9th World Congress of Psycho-Oncology, London, UK
• Results from a Ph II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of Pertuzumab to Gemcitabine in patients with platinum-r...
  S Makhija, D Glenn, F Ueland, M Gold, D Dizon, V Paton, M Birkner, C-Y Lin, M Derynck, U Matulonis, European Cancer Conference 14, Barcelona, Spain
• Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with relapsed ovarian cancer.
  N Finkler, D Dizon, J Micha, P Braly, U Lassen, SA Engelholm, R Glasspool, E Crowley, S Li, P Buhl- Jensen, R Penson, AACR-NCI-EORTC Conference on Molecular targets, San Francisco, CA
• Assessing the impact of pertuzumab on symptom burden in patients with advanced ovarian cancer.
  D Dizon, V Paton, CY Lin, D Lalla, International Society on Quality of Life Annual Meeting, Toronto, Ontario
• Evaluating the impact of pertuzumab on patient reported symptoms in advanced ovarian cancer.
  D Dizon, V Paton, CY Lin, D Lalla, European Society of Gynecologic Oncology Annual Meeting, Berlin, Germany
• Results from a Ph II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of Pertuzumab to Gemcitabine in patients with platinum-r...
  S Makhija, D Glenn, F Ueland, M Gold, D Dizon, V Paton, M Birkner, C-Y Lin, M Derynck, U Matulonis, European Society of Gynecologic Oncology Annual Meeting, Berlin, Germany
• Phase (Ph) I/II study of the histone deacetylase inhibitor belinostat (Bel) in combination with Carboplatin (Ca) and Paclitaxel (P) in advanced solid tumors (Ph I) and...
  U Lassen, P Braly, JS deBono, P Celano, D Dizon, R Glasspool, J Micha, RT Penson, N Finkler, 33rd European Society of Medical Oncology Congress. Stockholm, Sweden
• Gynecologic Oncology Tumor Board recommendations: eligibility for clinical trials vs. actual enrollment.
  L Kuroki, A Stuckey, E Feller, C Granai, D Dizon, International Gynecologic Cancer Society Meeeting (IGCS-12). Bangkok, Thailand
• Pertuzumab in low HER3 mRNA expressing platinum-resistant ovarian cancer.
  S Makhija, D Dizon, RA Walker, L Amler, D Loecke, M Venturi, S Kaye, ESGO 2009 Meeting, Belgrade, Serbia
• Long-term use of pegylated liposomal doxorubicin in recurrent ovarian cancer.
  B Cronin and DS Dizon, ESGO 2009 Meeting, Belgrade, Serbia
• Pegylated liposomal doxorubicin in recurrent serous carcinoma of the uterus.
  A Stuckey, J Schwartz, D Dizon, ESGO 2009 Meeting, Belgrade, Serbia
• Locally advanced vulvar cancer in elderly women: is chemoradiation beneficial?
  A Stuckey, M Schutzer, D Dizon, Int J of Gynecol Cancer 2010; 20 Suppl 2
• Advances in the management of ovarian cancer.
  DS Dizon, Highlights from the Gynecologic Oncology Group 86th Semi-Annual Meeting. Educational Concepts Group
• Continuing the mission for Interdisciplinary Breast Care.
  J Gass and DS Dizon, 2007 National Consortium of Breast Centers Annual Meeting. RT Image Magazine
• Breast Center Evolution.
  Don S. Dizon and Constance A. Roche, NCBC Annual Meeting 2007. Am J Clin Onc, 2007; 30:444-60, The 17th Annual National Interdisciplinary Breast Center Conference
• Breast care in 2011 and beyond: State of Policy, State of Science.
  Gass JS, Bell J, Dizon DS, Expert Rev Anticancer Ther 2011; 6:837-39
• Endometrial cancer: Present state and future promise.
  DS Dizon, KH Lu, and DS Miller, 2011 Educational Book. American Society of Clinical Oncology
• A comparison of gene expression analyses in SKOV-3 wild-type and resistant ovarian carcinoma cells following treatment with cisplatin and a non-cross-resistant platinu...
  DS Dizon, XJ Yan, DR Spriggs, American Association for Cancer Research, 92nd Annual Meeting, New Orleans, LA
• Carboplatin and paclitaxel as initial second line therapy in women with recurrent epithelial ovarian cancer.
  DS Dizon, M Hensley, P Sabbatinni, C Aghajanian, E Poynor, E Venkatraman, A Hummer, DR Spriggs, American Society of Clinical Oncology Annual Meeting 2001. San Francisco, CA
• A Phase I Trial of the Novel Proteasome Inhibitor PS341 in Advanced Solid Tumor Malignancies.
  C Aghajanian, S Soignet, DS Dizon, S Pezzulli, A Daud, DR Spriggs, J Adams, P Elliott, C Pien, American Society of Clinical Oncology Annual Meeting 2001. San Francisco, CA
• Platinum retreatment of platinum refractory ovarian cancer after non-platinum therapy.
  DR Spriggs, M Letaio, A Hummer, DS Dizon, P Sabbatini, C Aghajanian, M Hensley, E Venkatraman, American Society of Clinical Oncology Annual Meeting 2002. Orlando, FL
• CO2 pneumoperitoneum does not reduce the survival of women with persistent metastatic ovarian cancer.
  NR Abu-Rustum, Y Sonoda, DS Chi, DS Dizon, E Venkatraman, RR Barakat, Society of Gynecologic Oncologists 34th Annual Meeting. New Orleans, LA
• Join now to see all

Lectures

• New Approaches for Less Studied Tumors 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• New Strategies in the clinical treatment of endometrial cancer. 
  The Chemotherapy Foundation Symposium XXVII, New York City
• Screening Mammography in Women Aged 40-49. 
  National Consortium of Breast Centers Annual Meeting, Las Vegas
• Medical Oncology Basics. 
  National Consortium of Breast Centers Annual Meeting, Las Vegas
• Options in the Treatment of relapsed endometrial cancer: beyond first-line therapy. 
  Annual Meeting of the American Society of Clinical Oncology, Chicago
• Endometrial Cancer: Present State and Future Promise. 
  Annual Meeting of the American Society of Clinical Oncology, Chicago
• Cervical Cancer: Screening and Prevention Sexuality and Fertility: talking with your male and female patients about their options. 
  Sixth Annual Oncology Congress, San Francisco
• Preparing for survivorship: Quality of life of breast cancer survivors. Assessments and Interventions. 
  International Society for Sexuality and Medicine Symposium, Washington, DC
• Fertility and Sexuality. 
  Core Curriculum Seminar, Vanderbilt University School of Medicine, Nashville, TN
• Intimacy and Sexuality. 
  Living Beyond Breast Cancer Conference, Philadelphia, PA
• Complementary methods for managing symptoms and side effects. 
  Living Beyond Breast Cancer Conference, Philadelphia, PA
• Clinical Science Symposium Discussant: Can we personalize cervical cancer therapy? 
  American Society of Clinical Oncology Annual Meeting, Chicago, IL
• Sexuality and Cancer Issues. 
  Foundation for Women’s Cancers,Boston, MA
• Advancing medicine in clinical trials, Improving Management Strategies Ovarian Cancer Patients: Clinical Practice Patterns, Evolving Data, and Clinical Trial Awareness. 
  San Diego, CA
• Sexual Health Fundamentals. 
  National Consortium of Breast Centers Pre-Conference, Las Vegas, NV
• Communicating Cancer. 
  National Consortium of Breast Centers Annual Meeting, Las Vegas, NV
• Management of Ovarian Cancer. 
  South American Cancer Conference, Quito, Ecuador
• Management of Cervical Cancer. 
  South American Cancer Conference, Quito, Ecuador
• Ovarian Cancer: Diagnosis to Treatment. 
  Guam Medical Association, Tumon, Guam
• Blocking HER Dimerization: Preclinical and Early Clinical Evaluation of Pertuzumab. 
  The Fifth International Congress on Monoclonal Antibodies in Cancer. Quebec City, Canada
• From Bench to Bedside: The Clinical Development of Pertuzumab in Women’s Cancers. 
  International Conference on Drug Discovery and Delivery, Dubai, UAE
• Interactive Tumor Board: Breast Cancer. 
  International Gynecologic Cancer Society Meeting (IGCS-12). Bangkok, Thailand
• Breast Cancer. 
  International Gynecologic Cancer Society Meeting (IGCS-12). Bangkok, Thailand
• Results from a phase II trial of ixabepilone for women with advanced endometrial cancer (GOG-129P). 
  International Gynecologic Cancer Society Meeting (IGCS-12). Bangkok, Thailand
• Current options in chemoprevention. 
  Ville Marie Oncology Center 15th Anniversary Breast Cancer Conference, Quebec
• Join now to see all

Other

• Quality of life after breast cancer: survivorship and sexuality. 
  DS Dizon, The Breast Journal. 2009; 15:500-4
• Treatment options for advanced endometrial cancer. 
  DS Dizon, Gynecologic Oncology 2010; 117:373-81
• Where do anti-angiogenic agents belong in the treatment algorithm for ovarian cancer? 
  DS Dizon, American J Clin Oncol, 2011
• Sexual dysfunction following breast cancer treatment: common problems, diagnosis, and management. 
  A Kuo, DL Wiggins, and DS Dizon, SRM: Sexuality, Reproduction, and Menopause, 2008; 6:17-20
• The sexuality clinic in the breast center: sex as a survivorship issue. 
  DS Dizon, CA Duffy, DS Thompson, DL Wiggins, Breast Cancer Online 2008; 1:1-3. doi:10.1017/S`47090310800802X
• Perspective: Help or harm: Adjuvant therapies for primary invasive disease and the risk of a second contralateral breast cancer. 
  DS Dizon and JS Gass, Am Journal of Hemat and Oncol
  http://www.ajho.com/Help-or-harm-Adjuvant-therapies-for-primary-invasive-disease-and-the-risk-of-a-s
• Ixabepilone as a second-line treatment in advanced endometrial cancer. 
  N Kawar and DS Dizon, Asian-Pacific Journal of Hematology and Oncology
• Treating Locally advanced, Recurrent or Metastatic Endometrial Cancer: A Focus on Ixabepilone. 
  K Kilfoyle and DS Dizon, European Journal of Medical Oncology. 2010; 2:65-70
• Is there sex for women after cancer. 
  A Katz and DS Dizon, Coping magazine
• Moving Beyond Standard of Care: Novel Treatments in Gynecologic Cancer. 
  K Robison and DS Dizon, Contemporary Oncology
• Adjuvant therapy for endometrial cancer: “sandwich therapy” of carboplatin and paclitaxel with radiation therapy. 
  DS Dizon, CK McCourt, T Martin-Hanley, L Brard, AM Bradley, C Bandera, Cancer Therapy, 2007; 5:395-400
  http://www.cancer-therapy.org/articles5B.html
• Breast cancer Task Force SGO Position Paper. 
  J Orr, J Kelley, D Dizon, P Escobar, E Fleming, M Gemignani, D Hetzel, W Hoskins, J Lapolla, S Lwein, J Lucci, M Markman, B Pothuri, B Powell, T Tejada-Berges, L Kilgore, Gynecol Oncol 2008; 110:7-12
• Practical guidance: The use of social media. 
  Dizon DS, Graham D, Thompson MA, Johnson L, Johnston C, Fisch M, and Miller R, J Oncol Pract 2012; 8:e114-24
• Medical therapy of endometrial cancer: Current status and promising novel treatments. 
  Hill EK and Dizon DS, Drugs 2012; 26:72:705-13
• Sexual dysfunction in female cancer survivors. 
  DeSimone M, Spriggs E, Gass JS, Carson SA, Krychman ML, and Dizon DS, Am J Clin Oncol
• Novel antiangiogenic therapies in ovarian cancer. 
  Stuckey A and Dizon DS, Womens Health (London Engl) 2012; 8:447-53
• Preparing for Survivorship: Quality of Life in Breast Cancer Survivors. 
  Gao J and Dizon DS, Journal of Sex Medicine 2013; 10 (Suppl 1):16-20
• Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. 
  EH Romond, EA Perez, J Bryant, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel V..., New Engl J Med 2005; 353:1673-84
• Phase II study of bevacizumab in patients with platinum-resistnat ovarian or peritoneal serous cancer. 
  Cannistra SA, Matulonis UA, Penson RT, Hambleton J, Dupont J, Mackey H, Douglas J, Burger RA, Armstrong D, Wenham R, McGuire W, J Clin Oncol 2007; 25:5150-2
• Randomized, double-blind placebo controlled phase II study of AMG386 combined with weekly paclitaxel in patients with recurrent ovarian cancer. 
  Karlan BY, Oza AM, Richardson GE, Provencher Dm, Hansen VL, Buck M, Chambers SK, Ghatage P, Pippit CH Jr, Brown JV 3rd, Covens A, Nagarkar RV, Davy M, Leath CA 3rd, Ng..., J Clin Oncol 2012; 30:362-71
• Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. 
  Ledermann J, Harter P, Gourley C, et al, N Engl J Med 2012; 366:1382
• Incorporating targeted treatments into standard regimens: whither the role of established doses? 
  DS Dizon, Cancer Investigation 2004; 6:954
• Blocking HER dimerization: the clinical development of Pertuzumab in ovarian cancer. 
  DS Dizon, Advances in Ovarian Cancer, 2005: 3-6
• Join now to see all